Related Experiment Video
Updated: Jun 13, 2026

Biology of Microbial Communities - Interview
Published on: May 28, 2007
Healthcare-associated versus community-acquired infections: a new challenge for science and society
1Institute of Hygiene and Environmental Medicine, Charité University Medicine Berlin, National Reference Centre for Surveillance of Nosocomial Infections, Hindenburgdamm 27, D-12203 Berlin, Germany. Petra.Gastmeier@charite.de
Abstract:
Healthcare and community associated MRSA are meanwhile exchanged in all directions between hospitals, long-term care facilities, nursing homes, and the community. This article is focusing on the situation concerning MRSA, but the situation concerning other multidrug-resistant (MDR) pathogens such as vancomycin-resistant enterococci or MDR Gram-negative pathogens is similar. Some European countries have started national campaigns to improve the situation significantly. They require the successful cooperation between healthcare facilities, public health authorities, health insurances, quality management and patient safety organizations, educational facilities, the public, and the veterinarian sector. These activities in the society need scientific data to provide evidence for the intervention measures and support their implementation. To really support the activities in the society, intervention studies are urgently needed to provide a more robust basis for decisions to improve the situation.
Insights
Healthcare-associated infections like Methicillin-resistant Staphylococcus aureus (MRSA) spread between facilities and the community. More intervention studies are needed to support national campaigns tackling multidrug-resistant pathogens.
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat due to its spread between healthcare settings and the community.
- The transmission dynamics of MRSA are similar to other multidrug-resistant (MDR) pathogens, including vancomycin-resistant enterococci and MDR Gram-negative bacteria.
- Several European countries have initiated national strategies to combat MDR pathogens.
Purpose of the Study:
- To highlight the urgent need for scientific data and intervention studies to support national campaigns against MRSA and other MDR pathogens.
- To emphasize the necessity of intersectoral cooperation for effective control measures.
Main Methods:
- This article reviews the current situation regarding MRSA and other MDR pathogens.
- It discusses the requirements for successful national campaigns, emphasizing collaboration among various stakeholders.
- The need for evidence-based interventions is highlighted.
Main Results:
- MRSA and other MDR pathogens are frequently exchanged between hospitals, long-term care facilities, nursing homes, and the community.
- Successful national campaigns require cooperation between healthcare facilities, public health authorities, insurers, quality organizations, educational institutions, the public, and the veterinary sector.
- Current scientific data is insufficient to fully support and implement intervention measures effectively.
Conclusions:
- Intervention studies are urgently required to provide a robust evidence base for decision-making in combating MDR pathogens.
- Enhanced collaboration and data generation are crucial for improving the control of healthcare-associated infections and community-associated infections caused by MRSA and other MDR pathogens.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Infectious Diseases and Their Occurrence
Clinical Significance of Antibiotic Resistance

